[1]
|
Saunders, W. (2011) Dorland’s Illustrated Medical Dictionary, 2007. Saunders Elsevier, Philadelphia.
|
[2]
|
Alekshun, M.N. and Levy, S.B. (2007) Molecular Mechanisms of Antibacterial Multidrug Resistance. Cell, 128, 1037-1050. https://doi.org/10.1016/j.cell.2007.03.004
|
[3]
|
Watanabe, T. (1963) Infective Heredity of Multiple Drug Resistance in Bacteria. Microbiology and Molecular Biology Reviews, 27, 87-115. https://doi.org/10.1128/BR.27.1.87-115.1963
|
[4]
|
Leplae, R., Lima-Mendez, G. and Toussaint, A. (2006) A First Global Analysis of Plasmid Encoded Proteins in the ACLAME Database. FEMS Microbiology Reviews, 30, 980-994. https://doi.org/10.1111/j.1574-6976.2006.00044.x
|
[5]
|
Shaikh, S., Fatima, J., Shakil, S., Rizvi, S.M. and Kamal, M.A. (2015) Antibiotic Resistance and Extended Spectrum Beta-Lactamases: Types, Epidemiology and Treatment. Saudi Journal of Biological Sciences, 22, 90-101. https://doi.org/10.1016/j.sjbs.2014.08.002
|
[6]
|
Steward, C.D., Wallace, D., Hubert, S.K., Lawton, R., Fridkin, S.K., Gaynes, R.P., McGowan Jr., J.E. and Tenover, F.C. (2000) Ability of Laboratories to Detect Emerging Antimicrobial Resistance in Nosocomial Pathogens: A Survey of Project ICARE Laboratories. Diagnostic Microbiology and Infectious Disease, 38, 59-67. https://doi.org/10.1016/S0732-8893(00)00161-9
|
[7]
|
Sharma, M., Pathak, S. and Shrivastava, P. (2013) Prevalence and Antibiogram of Extended Spectrum b-Lactamase (ESBL) Producing Gram Negative Bacilli and Further Molecular Characterization of ESBL Producing Escherichia coli and Klebsiella spp. Journal of Clinical and Diagnostic Research, 7, 2168-2172.
|
[8]
|
Mirza, S., Jadhav, S., Misra, R.N. and Das, N.K. (2019) Coexistence of β-Lactamases in Community-Acquired Infections in a Tertiary Care Hospital in India. International Journal of Microbiology, 2019, Article ID: 7019578. https://doi.org/10.1155/2019/7019578
|
[9]
|
Bush, K. and Jacoby, G.A. (2010) Updated Functional Classification of β-Lactamases. Antimicrobial Agents and Chemotherapy, 54, 969-976. https://doi.org/10.1128/AAC.01009-09
|
[10]
|
Pitout, J.D.D. (2010) Infections with Extended Spectrum Beta Lactamase-Producing Enterobacteriaceae: Changing Epidemiology and Drug Treatment Choices. Drugs, 70, 313-333. https://doi.org/10.2165/11533040-000000000-00000
|
[11]
|
Paterson, D.L. and Bonomo, R.A. (2005) Extended-Spectrum β-Lactamases: A Clinical Update. Clinical Microbiology Reviews, 18, 657-686. https://doi.org/10.1128/CMR.18.4.657-686.2005
|
[12]
|
De Araújo Viana Marques, D., Machado, S.E.F., Ebinuma, V.C.S., De Albuquerque Lima Duarte, C., Converti, A. and Porto, A.L.F. (2018) Production of β-Lactamase Inhibitors by Streptomyces Species. Antibiotics, 7, 61. https://doi.org/10.3390/antibiotics7030061
|
[13]
|
Hawkey, P. and Finch, R. (2007) Tigecycline: In-Vitro Performance as a Predictor of Clinical Efficacy. Clinical Microbiology and Infection, 13, 354-362. https://doi.org/10.1111/j.1469-0691.2006.01621.x
|
[14]
|
Walsh, T.R. (2008) Clinically Significant Carbapenemases: An Update. Current Opinion in Infectious Diseases, 21, 367-371. https://doi.org/10.1097/QCO.0b013e328303670b
|
[15]
|
Mena, A., Plasencia, V., Garcia, L., Hidalgo, O., Ayestaran, J.I., Alberti, S., Borrell, N., Perez, J.L. and Oliver, A. (2006) Characterization of a Large Outbreak by CTX-M-1-Producing Klebsiella pneumoniae and Mechanisms Leading to in Vivo Carbapenem Resistance Development. Journal of Clinical Microbiology, 44, 2831-2837. https://doi.org/10.1128/JCM.00418-06
|
[16]
|
Gautam, V., Thakur, A., Sharma, M., Singh, A., Bansal, S., Sharma, A., Kapil, A., Das, B.K., Sistla, S., Parija, S.C., Veeraraghavan, B., Prakash, J.A.J., Walia, K., Ohri, V.C. and Ray, P. (2019) Molecular Characterization of Extended-Spectrum β-Lactamases among Clinical Isolates of Escherichia coli and Klebsiella pneumoniae: A Multi-Centric Study from Tertiary Care Hospitals in India. Indian Journal of Medical Research, 149, 208-215. https://doi.org/10.4103/ijmr.IJMR_172_18
|
[17]
|
Grover, S.S., Doda, A., Gupta, N., Gandhoke, I., Batra, J., Hans, C. and Khare, S. (2017) New Delhi Metallo-β-Lactamase-Type Carbapenemases Producing Escherichia coli Isolates from Hospitalized Patients: A Pilot Study. Indian Journal of Medical Research, 146, 105-110. https://doi.org/10.4103/ijmr.IJMR_594_15
|
[18]
|
Hall, B.G. and Barlow, M. (2004) Evolution of the Serine β-Lactamases: Past, Present and Future. Drug Resistance Updates, 7, 111-123. https://doi.org/10.1016/j.drup.2004.02.003
|
[19]
|
Poole, K. (2004) Resistance to β-Lactam Antibiotics. Cellular and Molecular Life Sciences, 61, 2200-2223. https://doi.org/10.1007/s00018-004-4060-9
|
[20]
|
Marcade, G., Deschamps, C., Boyd, A., Gautier, V., Picard, B., Branger, C., Denamur, E. and Arlet, G. (2009) Replicon Typing of Plasmids in Escherichia coli Producing Extended-Spectrum β-Lactamases. Journal of Antimicrobial Chemotherapy, 63, 67-71. https://doi.org/10.1093/jac/dkn428
|
[21]
|
Bauernfeind, A., Grimm, H. and Schweighart, S. (1990) A New Plasmidic Cefotaximase in a Clinical Isolate of Escherichia coli. Infection, 18, 294-298. https://doi.org/10.1007/BF01647010
|
[22]
|
Alsterlund, R., Axelsson, C. and Olsson-Liljequist, B. (2012) Long-Term Carriage of Extended-Spectrum Beta-Lactamase-Producing Escherichia coli. Scandinavian Journal of Infectious Diseases, 44, 51-54. https://doi.org/10.3109/00365548.2011.592987
|
[23]
|
Jostins, L., Ripke, S., Weersma R.K., et al. (2012) Host-Microbe Interactions Have Shaped the Genetic Architecture of Inflammatory Bowel Disease. Nature, 491, 119-124. https://doi.org/10.1038/nature11582
|
[24]
|
Garau, G., Bebrone, C., Anne, C., Galleni, M., Frere, J. and Dideberg, O. (2005) A Metallo-Beta-Lactamase Enzyme in Action: Crystal Structures of the Monozinc carbapenemases CphA and Its Complex with Biapenem. Journal of Molecular Biology, 345, 785-795. https://doi.org/10.1016/j.jmb.2004.10.070
|
[25]
|
Golemi-Kotra, D., Meroueh, S., Kim, C., Vakulenko, S., Bulychev, A., Stemmler, A, Stemmler, T. and Mobasherry. (2004) The Importance of a Critical Protonation State and the Fate of the Catalytic Steps in Class A Beta-Lactamases and Penicillin-Binding Proteins. Journal of Biological Chemistry, 279, 34665-34673. https://doi.org/10.1074/jbc.M313143200
|
[26]
|
Meroueh, S.O., Fisher, J.F., Schlegel, H.B. and Mobashery, S. (2005) Ab Initio QM/MM Study of Class A Beta-Lactamase Acylation: Dual Participation of Glu166 and Lys73 in a Concerted Base Promotion of Ser70. Journal of the American Chemical Society, 127, 15397-15407. https://doi.org/10.1021/ja051592u
|
[27]
|
Ambler, R.P. (1980) The Structure of Beta-Lactamases. Philosophical Transactions of the Royal Society B: Biological Sciences, 289, 321-331. https://doi.org/10.1098/rstb.1980.0049
|
[28]
|
Matagne, A., Lamotte-Brasseur, J. and Frere, J.M. (1998) Catalytic Properties of Class A-Lactamases: Efficiency and Diversity. Biochemical Journal, 330, 581-598. https://doi.org/10.1042/bj3300581
|
[29]
|
Ambler, R.P., Coulson, A.F., Frere, J.M., Ghuysen, J.M., Joris, B., Forsman, M., Levesque, R.C., Tiraby, G. and Waley, S.G. (1991) A Standard Numbering Scheme for the Class A Beta-Lactamases. Biochemical Journal, 276, 269-270. https://doi.org/10.1042/bj2760269
|
[30]
|
Risso, V.A., Gavira, J.A., Mejia-Carmona, D.F., Gaucher, E.A. and Sanchez-Ruiz, J.M. (2013) Hyperstability and Substrate Promiscuity in Laboratory Resurrections of Precambrian β-Lactamases. Journal of the American Chemical Society, 135, 2899-2902. https://doi.org/10.1021/ja311630a
|
[31]
|
Tranier, S., Bouthors, A.T., Maveyraud, L., Guillet, V., Sougakoff, W. and Samama, J.P. (2000) The High Resolution Crystal Structure for Class A β-Lactamase PER-1 Reveals the Bases for Its Increase in Breadth of Activity. Journal of Biological Chemistry, 275, 28075-28082. https://doi.org/10.1074/jbc.M003802200
|
[32]
|
Ruggiero, M., Kerff, F., Herman, R., Sapunaric, F., Galleni, M., Gutkind, G., Charlier, P., Sauvage, E. and Power, P. (2014) Crystal Structure of the Extendedspectrum β-Lactamase PER-2 and Insights into the Role of Specific Residues in the Interaction with β-Lactams and β-Lactamase Inhibitors. Antimicrobial Agents and Chemotherapy, 58, 5994-6002. https://doi.org/10.1128/AAC.00089-14
|
[33]
|
Wang, F., Cassidy, C. and Sacchettini, J.C. (2006) Crystal Structure and Activity Studies of the Mycobacterium tuberculosis Beta-Lactamase Reveal Its Critical Role in Resistance to Beta-Lactam Antibiotics. Antimicrobial Agents and Chemotherapy, 50, 2762-2771. https://doi.org/10.1128/AAC.00320-06
|
[34]
|
Ke, W., Bethel, C.R., Papp-Wallace, K.M., Pagadala, S.R., Nottingham, M., Fernandez, D., Buynak, J.D., Bonomo, R.A. and van den Akker, F. (2012) Crystal Structures of KPC-2 β-Lactamase in Complex with 3-Nitrophenyl Boronic Acid and the Penam Sulfone PSR-3-226. Antimicrobial Agents and Chemotherapy, 56, 2713-2718. https://doi.org/10.1128/AAC.06099-11
|
[35]
|
Philippon, A., Slama, P., Deny, P. and Labia, R. (2016) A Structure-Based Classification of Class A β-Lactamases, a Broadly Diverse Family of Enzymes. Clinical Microbiology Reviews, 29, 29-57. https://doi.org/10.1128/CMR.00019-15
|
[36]
|
Livermore, D.M. (2008) Defining an Extended-Spectrum β-Lactamase. Clinical Microbiology and Infection, 4, 3-10. https://doi.org/10.1111/j.1469-0691.2007.01857.x
|
[37]
|
McDanel, J., Schweizer, M., Crabb, V., Nelson, R., Samore, M., Khader, K., Blevins, A.E., Diekema, D., Chiang, H., Nair, R. and Perencevich, E. (2017) Incidence of Extended-Spectrum β-Lactamase (ESBL)-Producing Escherichia coli and Klebsiella Infections in the United States: A Systematic Literature Review. Infection Control & Hospital Epidemiology, 38, 1209-1215. https://doi.org/10.1017/ice.2017.156
|
[38]
|
Murray, T.S. and Peaper, D.R. (2015) The Contribution of Extended-Spectrum β-Lactamases to Multidrug-Resistant Infections in Children. Current Opinion in Pediatrics, 27, 124-131. https://doi.org/10.1097/MOP.0000000000000182
|
[39]
|
Bush, K., Jacoby, G.A. and Medeiros, A.A. (1995) A Functional Classification Scheme for β-Lactamases and Its Correlation with Molecular Structure. Antimicrobial Agents and Chemotherapy, 39, 1211-1233. https://doi.org/10.1128/AAC.39.6.1211
|
[40]
|
Datta, N. and Kontomichalou, P. (1965) Penicillinase Synthesis Controlled by Infectious R Factors in Enterobacteriaceae. Nature, 208, 239-241. https://doi.org/10.1038/208239a0
|
[41]
|
Rahman, S., Ali, T., Ali, I., Khan, N.A., Han, B. and Gao, J. (2018) The Growing Genetic and Functional Diversity of Extended Spectrum Beta-Lactamases. BioMed Research International, 2018, Article ID: 9519718. https://doi.org/10.1155/2018/9519718
|
[42]
|
Jacoby, G.A. (1997) Extended-Spectrum β-Lactamases and Other Enzymes Providing Resistance to Oxyimino-β-Lactams. Infectious Disease Clinics of North America, 11, 875-887. https://doi.org/10.1016/S0891-5520(05)70395-0
|
[43]
|
Sykes, R.B. and Bush, K. (1982) Physiology, Biochemistry, and Inactivation of β-Lactamases. In: Morin, R.B. and Gorman, M., Eds., The Biology of Beta-Lactam Antibiotics, Vol. 3, Academic Press, Waltham, 155-207. https://doi.org/10.1016/B978-0-12-506303-6.50008-X
|
[44]
|
Knothe, H., Shah, P., Krcmery, V., Antal, M. and Mitsuhashi, S. (1983) Transferable Resistance to Cefotaxime, Cefoxitin, Cefamandole and Cefuroxime in Clinical Isolates of Klebsiella pneumoniae and Serratia marcescens. Infection, 11, 315-317. https://doi.org/10.1007/BF01641355
|
[45]
|
Paterson, D.L., Hujer, K.M., Hujer, A.M., Yeiser, B., Bonomo, M.D., Rice, L.B. and Bonomo, R.A. (2003) Extended-Spectrum β-Lactamases in Klebsiella pneumoniae Bloodstream Isolates from Seven Countries: Dominance and Widespread Prevalence of SHV- and CTX-M-Type β-Lactamases. Antimicrobial Agents and Chemotherapy, 47, 3554-3560. https://doi.org/10.1128/AAC.47.11.3554-3560.2003
|
[46]
|
Perilli, M., Segatore, B., Mugnaioli, C., Celenza, G., Rossolini, G.M., Stefani, S., Luzzaro, F., Pini, B. and Amicosante, G. (2011) Persistence of TEM-52/TEM-92 and SHV-12 Extended-Spectrum Beta-Lactamases in Clinical Isolates of Enterobacteriaceae in Italy. Microbial Drug Resistance, 17, 521-524. https://doi.org/10.1089/mdr.2011.0059
|
[47]
|
Baraniak, A., Fiett, J., Hryniewicz, W., Nordmann, P. and Gniadkowski, M. (2002) Ceftazidime-Hydrolysing CTX-M-15 Extended-Spectrum β-Lactamase (ESBL) in Poland. Journal of Antimicrobial Chemotherapy, 50, 393-396. https://doi.org/10.1093/jac/dkf151
|
[48]
|
Yu, W.L., Pfaller, M.A., Winokur, P.L. and Jones, R.N. (2002) Cefepime MIC as a Predictor of the Extended-Spectrum β-Lactamase Type in Klebsiella pneumoniae, Taiwan. Emerging Infectious Diseases, 8, 522-524. https://dx.doi.org/10.3201/eid0805.010346
|
[49]
|
Decousser, J.W., Poirel, L. and Nordmann, P. (2001) Characterization of a Chromosomally Encoded Extended-Spectrum Class A β-Lactamase from Kluyvera cryocrescens. Antimicrobial Agents and Chemotherapy, 45, 3595-3598. https://doi.org/10.1128/AAC.45.12.3595-3598.2001
|
[50]
|
Naseer, U. and Sundsfjord, A. (2011) The CTX-M Conundrum: Dissemination of Plasmids and Escherichia coli Clones. Microbial Drug Resistance, 17, 83-97. https://doi.org/10.1089/mdr.2010.0132
|
[51]
|
Weldhagen, G.F., Poirel, L. and Nordmann, P. (2003) Ambler Class A Extended-Spectrum β-Lactamases in Pseudomonas aeruginosa: Novel Developments and Clinical Impact. Antimicrobial Agents and Chemotherapy, 47, 2385-2392. https://doi.org/10.1128/AAC.47.8.2385-2392.2003
|
[52]
|
Livermore, D.M. (1995) Beta-Lactamases in Laboratory and Clinical Resistance. Clinical Microbiology Reviews, 8, 557-584. https://doi.org/10.1128/CMR.8.4.557
|
[53]
|
Bradford, P.A. (2001) Extended-Spectrum β-Lactamases in the 21st Century: Characterization, Epidemiology, and Detection of This Important Resistance Threat. Clinical Microbiology Reviews, 14, 933-951. https://doi.org/10.1128/CMR.14.4.933-951.2001
|
[54]
|
Naas, T., Poirel, L. and Nordmann, P. (2008) Minor Extended-Spectrum β-Lactamases. Clinical Microbiology and Infection, 14, 42-52. https://doi.org/10.1111/j.1469-0691.2007.01861.x
|
[55]
|
Drawz, S.M. and Bonomo, R.A. (2010) Three Decades of Beta-Lactamase Inhibitors. Clinical Microbiology Reviews, 23, 160-201. https://doi.org/10.1128/CMR.00037-09
|
[56]
|
Al Jasser, A.M. (2006) Extended-Spectrum Beta-Lactamase (ESBLS): A Global Problem. Kuwait Medical Journal, 38, 171-185.
|
[57]
|
Sturenburg, E., and Mack, D. (2003) Extended-Spectrum β-Lactamases: Implications for the Clinical Microbiology Laboratory, Therapy, and Infection Control. Journal of Infection, 47, 273-295. https://doi.org/10.1016/S0163-4453(03)00096-3
|
[58]
|
Bouchillon, S.K., Johnson, B.M., Hoban, D.J., Johnson, J.L., Dowzicky, M.J., Wu, D.H., Visalli, M.A. and Bradford, P.A. (2004) Determining Incidence of Extended Spectrum β-Lactamase Producing Enterobacteriaceae, Vancomycin-Resistant Enterococcus faecium and Methicillin-Resistant Staphylococcus aureus in 38 Centers from 17 Countries: The PEARLS Study 2001-2002. International Journal of Antimicrobial Agents, 24, 119-124. https://doi.org/10.1016/j.ijantimicag.2004.01.010
|
[59]
|
Coque, T.M., Baquero, F., and Canton, R. (2008) Increasing Prevalence of ESBL-Producing Enterobacteriaceae in Europe. Eurosurveillance, 13, Article ID: 19044.
|
[60]
|
Oteo, J., Campos, J. and Baquero, F. (2002) Antibiotic Resistance in 1962 Invasive Isolates of Escherichia coli in 27 Spanish Hospitals Participating in the European Antimicrobial Resistance Surveillance System (2001). Journal of Antimicrobial Chemotherapy, 50, 945-952. https://doi.org/10.1093/jac/dkf255
|
[61]
|
Albertini, M.T., Benoit, C., Berardi, L., Berrouane, Y., Boisivon, A., Cahen, P., Cattoen, C., Costa, Y., Darchis, P., Deliere, E., Demontrond, D., et al. (2002) Surveillance of Methicillin-Resistant Staphylococcus aureus (MRSA) and Enterobacteriaceae Producing Extended-Spectrum Beta-Lactamase (ESBLE) in Northern France: A Five-Year Multicentre Incidence Study. The Journal of Hospital Infection, 52, 107-113. https://doi.org/10.1053/jhin.2002.1286
|
[62]
|
Bradford, P.A., Cherubin, C.E., Idemyor, V., Rasmussen, B.A. and Bush, K. (1994) Multiple Resistant Klebsiella pneumoniae Strains from Two Chicago Hospitals: Identification of the Extended-Spectrum TEM-12 and TEM-10 Ceftazidime-Hydrolyzing Beta-Lactamases in a Single Isolate. Antimicrobial Agents and Chemotherapy, 38, 761-766. https://doi.org/10.1053/jhin.2002.1286
|
[63]
|
Nordmann, P., Poirel, L., Toleman, M.A. and Walsh, T.R. (2011) Does Broad-Spectrum β-Lactam Resistance Due to NDM-1 Herald the End of the Antibiotic Era for Treatment of Infections Caused by Gram-Negative Bacteria? Journal of Antimicrobial Chemotherapy, 66, 689-692. https://doi.org/10.1093/jac/dkq520
|
[64]
|
Pitout, J.D.D., Campbell, L., Church, D.L., Gregson, D.B. and Laupland, K.B. (2009) Molecular Characteristics of Travel-Related Extended-Spectrum-β-Lactamase-Producing Escherichia coli Isolates from the Calgary Health Region. Antimicrobial Agents and Chemotherapy, 53, 2539-2543. https://doi.org/10.1128/AAC.00061-09
|
[65]
|
Paterson, D.L., Singh, N., Rihs, J.D., Squier, C., Rihs, B.L. and Muder, R.R. (2001) Control of an Outbreak of Infection Due to Extended-Spectrum Beta-Lactamase-Producing Escherichia coli in a Liver Transplantation Unit. Clinical Infectious Diseases, 33, 126-128. https://doi.org/10.1086/320882
|
[66]
|
Gaillot, O., Maruejouls, C., Abachin, E., Lecuru, F., Arlet, G., Simonet, M. and Berche, P. (1998) Nosocomial Outbreak of Klebsiella pneumoniae Producing SHV-5 Extended-Spectrum β-Lactamase, Originating from a Contaminated Ultrasonography Coupling Gel. Journal of Clinical Microbiology, 36, 1357-1360. https://doi.org/10.1128/JCM.36.5.1357-1360.1998
|
[67]
|
Wiener, J., Quinn, J.P., Bradford, P.A., Goering, R.V, Nathan, C., Bush, K., and Weinstein, R.A. (1999) Multiple Antibiotic-Resistant Klebsiella and Escherichia coli in Nursing Homes. JAMA, 281, 517-523. https://doi.org/10.1001/jama.281.6.517
|
[68]
|
Marchandin, H., Carriere, C., Sirot, D., Jean-Pierre, H. and Darbas, H. (1999) TEM-24 Produced by Four Different Species of Enterobacteriaceae, Including Providencia Rettgeri, in a Single Patient. Antimicrobial Agents and Chemotherapy, 43, 2069-2073. https://doi.org/10.1128/AAC.43.8.2069
|
[69]
|
Jain, A. and Mondal, R. (2007) Prevalence & Antimicrobial Resistance Pattern of Extended Spectrum Beta-Lactamase Producing Klebsiella spp Isolated from Cases of Neonatal Septicaemia. Indian Journal of Medical Research, 125, 89-94.
|
[70]
|
Mathai, D., Rhomberg, P.R., Biedenbach, D.J. and Jones, R.N. (2002) Evaluation of the in Vitro Activity of Six Broad-Spectrum β-Lactam Antimicrobial Agents Tested against Recent Clinical Isolates from India: A Survey of Ten Medical Center Laboratories. Diagnostic Microbiology and Infectious Disease, 44, 367-377. https://doi.org/10.1016/S0732-8893(02)00466-2
|
[71]
|
Gupta, V. and Datta, P. (2007) Extended-Spectrum Beta-Lactamases (ESBL) in Community Isolates from North India: Frequency and Predisposing Factors. International Journal of Infectious Diseases, 11, 88-89. https://doi.org/10.1016/j.ijid.2006.02.002
|
[72]
|
Jacoby, G.A., Walsh, K.E., Mills, D.M., Walker, V.J., Oh, H., Robicsek, A. and Hooper, D.C. (2006) qnrB, Another Plasmid-Mediated Gene for Quinolone Resistance. Antimicrobial Agents and Chemotherapy, 50, 1178-1182. https://doi.org/10.1128/AAC.50.4.1178-1182.2006
|
[73]
|
Dhawan, B., Bonnet, R., Shukla, N.K., Mathur, P., Das, B.K. and Kapil, A. (2003) Infection with an Extended-Spectrum β-Lactamase-Producing Strain of Serratia marcescens Following Tongue Reconstruction. Journal of Clinical Microbiology, 41, 2233-2234. https://doi.org/10.1128/JCM.41.5.2233-2234.2003
|
[74]
|
Revathi, G., Shannon, K.P., Stapleton, P.D., Jain, B.K., French, G.L. (1998) An Outbreak of Extended-Spectrum, β-Lactamase-Producing Salmonella senftenberg in a Burns Ward. Journal of Hospital Infection, 40, 295-302. https://doi.org/10.1016/S0195-6701(98)90307-3
|
[75]
|
Grover, S.S., Sharma, M., Chattopadhya, D., Kapoor, H., Pasha, S.T. and Singh G. (2006) Phenotypic and Genotypic Detection of ESBL Mediated Cephalosporin Resistance in Klebsiella pneumoniae: Emergence of High Resistance against Cefepime, the Fourth Generation Cephalosporin. Journal of Infection, 53, 279-288. https://doi.org/10.1016/j.jinf.2005.12.001
|
[76]
|
Karim, A., Poirel, L., Nagarajan, S. and Nordmann, P. (2001) Plasmid-Mediated Extended-Spectrum β-Lactamase (CTX-M-3 Like) from India and Gene Association with Insertion Sequence ISEcp1. FEMS Microbiology Letters, 201, 237-241. https://doi.org/10.1111/j.1574-6968.2001.tb10762.x
|
[77]
|
Ensor, V.M., Shahid, M., Evans, J.T. and Hawkey, P.M. (2006) Occurrence, Prevalence and Genetic Environment of CTX-M β-Lactamases in Enterobacteriaceae from Indian Hospitals. Journal of Antimicrobial Chemotherapy, 58, 1260-1263. https://doi.org/10.1093/jac/dkl422
|
[78]
|
Walsh, T.R., Toleman, M.A. and Jones, R.N. (2007) Comment on: Occurrence, Prevalence and Genetic Environment of CTX-M β-Lactamases in Enterobacteriaceae from Indian Hospitals. Journal of Antimicrobial Chemotherapy, 59, 799-800. https://doi.org/10.1093/jac/dkl532
|
[79]
|
Pitout, J.D. and Laupland, K.B. (2008) Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae: An Emerging Public-Health Concern. The Lancet Infectious Diseases, 8, 159-166. https://doi.org/10.1016/S1473-3099(08)70041-0
|
[80]
|
Bell, J.M., Turnidge, J.D., Gales A.D., Pfaller, M.A., Jones, R.N., Sentry APAC Study Group. (2002) Prevalence of Extended Spectrum Beta-Lactamase (ESBL)-Producing Clinical Isolates in the Asia-Pacific Region and South Africa: Regional Results from SENTRY Antimicrobial Surveillance Program (1998-99). Diagnostic Microbiology and Infectious Disease, 42, 193-198. https://doi.org/10.1016/S0732-8893(01)00353-4
|
[81]
|
Manjula, N.G, Math, G.C., Patil, S.A., Gaddad, S.M. and Shivannavar, C.T. (2014) Prevalence of MDR-ESBL Producing Escherichia coli Isolated from Urinary Tract Infections of Pregnant Women in Karnataka. Journal of Pure and Applied Microbiology, 8, 3765-3771.
|
[82]
|
Hirakata, Y., Matsuda, J., Miyazaki, Y., Kamihira, S., Kawakami, S., Miyazawa, Y., Ono, Y., Nakazaki, N., Hirata, Y., Inoue, M., Turnidge, J.D., Bell, J.M., Jones, R.N., Kohno, S. and SENTRY Asia Pacific Participants (2005) Regional Variation in the Prevalence of Extended-Spectrum β-Lactamase-Producing Clinical Isolates in the Asia-Pacific Region (SENTRY 1998-2002). Diagnostic Microbiology and Infectious Disease, 52, 323-329. https://doi.org/10.1016/j.diagmicrobio.2005.04.004
|
[83]
|
Subha, A. and Ananthan, S. (2002) Extended Spectrum Beta Lactamase (ESBL) Mediated Resistance to Third Generation Cephalosporins among Klebsiella pneumoniae in Chennai. Indian Journal of Medical Microbiology, 20, 92-95.
|
[84]
|
Babypadmini, S. and Appalaraju, B. (2004) Extended Spectrum-Lactamases in Urinary Isolates of Escherichia coli and Klebsiella pneumoniae-Prevalence and Susceptibility Pattern in a Tertiary Care Hospital. Indian Journal of Medical Microbiology, 22, 172-174.
|
[85]
|
Mathur, P., Kapil, A., Das, B. and Dhawan, B. (2005) Prevalence of Extended Spectrum Beta Lactamase Producing Gram Negative Bacteria in a Tertiary Care Hospital. Indian J Med Res, 115, 153-157.
|
[86]
|
Singhal, S., Mathur, T., Khan, S., Upadhyay, D.J., Chugh, S., Gaind, R. and Rattan, A. (2005) Evaluation of Methods for AmpC Beta-Lactamase in Gram Negative Clinical Isolates from Tertiary Care Hospitals. Indian Journal of Medical Microbiology, 23, 120-124. https://doi.org/10.4103/0255-0857.16053
|
[87]
|
Rodrigues, C., Joshi, P., Jani, S.H., Alphonse, M., Radhakrishnan, R. and Mehta, A. (2004) Detection of-Lactamases in Nosocomial Gram Negative Clinical Isolates. Indian Journal of Medical Microbiology, 22, 247-250.
|
[88]
|
Akram, M., Shahid, M. and Khan, A. U. (2007) Etiology and Antibiotic Resistance Patterns of Community-Acquired Urinary Tract Infections in JNMC Hospital Aligarh, India. Annals of Clinical Microbiology and Antimicrobials, 6, Article ID: 4. https://doi.org/10.1186/1476-0711-6-4
|
[89]
|
Ray, K., Mukhopadhyay, S., Dutt, D., Chatterjee, P.K., Roychowdhury, P.K., Roy, K. and Banerjee, S.N. (2003) Cross-Sectional Study of Consumption, Compliance and Awareness about Antibiotic Utilisation amongst the Urban Community in Kolkata. Journal of the Indian Medical Association, 101, 9-10.
|
[90]
|
Nicolas-Chanoine, M.H., Blanco, J., Leflon-Guibout, V., Demarty, R., Alonso, M.P., Canica, M.M., Park, Y.J., Lavigne, J.P., Pitout, J. and Johnson, J.R. (2008) Intercontinental Emergence of Escherichia Coli Clone O25: H4-ST131 Producing CTX-M-15. Journal of Antimicrobial Chemotherapy, 61, 273-281. https://doi.org/10.1093/jac/dkm464
|
[91]
|
Muzaheed, D.Y., Adam-Haduch, J.M., Endimiani, A, Sidjabat, H.E., Gaddad, S.M. and Paterson, D.L. (2008) High Prevalence of CTX-M-15-Producing Klebsiella pneumoniae among Inpatients and Outpatients with Urinary Tract Infection in Southern India. Journal of Antimicrobial Chemotherapy, 61, 1393-1394. https://doi.org/10.1093/jac/dkn109
|
[92]
|
Yan, J.J., Ko, W.C. and Wu, J.J. (2001) Identification of a Plasmid Encoding SHV-12, TEM-1, and a Variant of IMP-2 Metallo-β-Lactamase, IMP-8, from a Clinical Isolate of Klebsiella pneumoniae. Antimicrobial Agents and Chemotherapy, 45, 2368-2371. https://doi.org/10.1128/AAC.45.8.2368-2371.2001
|
[93]
|
Payne, D.J. (1993) Metallo-β-Lactamases—New Therapeutic Challenge. Journal of Medical Microbiology, 39, 93-99. https://doi.org/10.1099/00222615-39-2-93
|
[94]
|
Murphy, T.A., Simm, A.M., Toleman, M.A., Jones, R.N. and Walsh, T.R. (2003) Biochemical Characterization of the Acquired Metallo-β-Lactamase SPM-1 from Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy, 47, 582-587. https://doi.org/10.1128/AAC.47.2.582-587.2003
|
[95]
|
Rasmussen, B.A. and Bush, K. (1997) Carbapenem-Hydrolyzing Beta-Lactamases. Antimicrobial Agents and Chemotherapy, 41, 223-232. https://doi.org/10.1128/AAC.41.2.223
|
[96]
|
Kato, N., Yamazoe, K., Han, C.G. and Ohtsubo, E. (2003) New Insertion Sequence Elements in the Upstream Region of cfiA in Imipenem-Resistant Bacteroides fragilis Strains. Antimicrobial Agents and Chemotherapy, 47, 979-985. https://doi.org/10.1128/AAC.47.3.979-985.2003
|
[97]
|
Daiyasu, H., Osaka, K., Ishino, Y. and Toh, H. (2001) Expansion of the Zinc Metallo-Hydrolase Family of the β-Lactamase Fold. FEBS Letters, 503, 1-6. https://doi.org/10.1016/S0014-5793(01)02686-2
|
[98]
|
Watanabe, M., Iyobe, S., Inoue, M. and Mitsuhashi, S. (1991) Transferable Imipenem Resistance in Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy, 35, 147-151. https://doi.org/10.1128/AAC.35.1.147
|
[99]
|
Livermore, D.M. (2001) Of Pseudomonas, Porins, Pumps and Carbapenems. Journal of Antimicrobial Chemotherapy, 47, 247-250. https://doi.org/10.1093/jac/47.3.247
|
[100]
|
Toleman, M.A., Biedenbach, D., Bennett, D., Jones, R.N. and Walsh. T.R. (2003) Genetic Characterization of a Novel Metallo-β-Lactamase Gene, blaIMP-13, Harboured by a Novel Tn5051-Type Transposon Disseminating Carbapenemase Genes in Europe: Report from the SENTRY Worldwide Antimicrobial Surveillance Programme. Journal of Antimicrobial Chemotherapy, 52, 583-590. https://doi.org/10.1093/jac/dkg410
|
[101]
|
Arakawa, Y., Murakami, M., Suzuki, K., Ito, H., Wacharotayankun, R., Ohsuka, S., Kato, N. and Ohta, M. (1995) A Novel Integron-Like Element Carrying the Metallo-Beta-Lactamase Gene blaIMP. Antimicrobial Agents and Chemotherapy, 39, 1612-1615. https://doi.org/10.1128/AAC.39.7.1612
|
[102]
|
Koh, T.H., Sng, L.H., Babini, G.S., Woodford, N., Livermore, D.M. and Hall, L.M. (2001) Carbapenem-Resistant Klebsiella pneumoniae in Singapore Producing IMP-1 β-Lactamase and Lacking an Outer Membrane Protein. Antimicrobial Agents and Chemotherapy, 45, 1939-1940. https://doi.org/10.1128/AAC.45.6.1939-1940.2001
|
[103]
|
Tysall, L., Stockdale, M.W., Chadwick, P.R., Palepou, M.F., Towner, K.J., Livermore, D.M. and Woodford, N. (2002) IMP-1 Carbapenemase Detected in an Acinetobacter Clinical Isolate from the UK. Journal of Antimicrobial Chemotherapy, 49, 217-218. https://doi.org/10.1093/jac/49.1.217
|
[104]
|
Riccio, M.L., Franceschini, N., Boschi, L., Caravelli, B., Cornaglia, G., Fontana, R., Amicosante, G. and Rossolini, G.M. (2000) Characterization of the Metallo-β-Lactamase Determinant of Acinetobacter baumannii AC-54/97 Reveals the Existence of blaIMP Allelic Variants Carried by Gene Cassettes of Different Phylogeny. Antimicrobial Agents and Chemotherapy, 44, 1229-1235. https://doi.org/10.1128/AAC.44.5.1229-1235.2000
|
[105]
|
Docquier, J.D., Riccio, M.L., Mugnaioli, C., Luzzaro, F., Endimiani, A., Toniolo, A., Amicosante, G. and Rossolini, G.M. (2003) IMP-12, a New Plasmid-Encoded Metallo-β-Lactamase from a Pseudomonas Putida Clinical Isolate. Antimicrobial Agents and Chemotherapy, 47, 1522-1528. https://doi.org/10.1128/AAC.47.5.1522-1528.2003
|
[106]
|
Iyobe, S., Kusadokoro, H., Ozaki, J., Matsumura, N., Minami, S., Haruta, S., Sawai, T. and O’Hara, K. (2000) Amino Acid Substitutions in a Variant of IMP-1 Metallo-Lactamase. Antimicrobial Agents and Chemotherapy, 44, 2023-2027. https://doi.org/10.1128/AAC.44.8.2023-2027.2000
|
[107]
|
Iyobe, S., Kusadokoro, H., Takahashi, A., Yomoda, S., Okubo, T., Nakamura, A. and O’Hara, K. (2002) Detection of a Variant Metallo-β-Lactamase, IMP-10, from Two Unrelated Strains of Pseudomonas aeruginosa and an Alcaligenes xylosoxidans Strain. Antimicrobial Agents and Chemotherapy, 46, 2014-2016. https://doi.org/10.1128/AAC.46.6.2014-2016.2002
|
[108]
|
Yano, H., Kuga, A., Okamoto, R., Kitasato, H., Kobayashi, T. and Inoue, M. (2001) Plasmid-Encoded Metallo-β-Lactamase (IMP-6) Conferring Resistance to Carbapenems, Especially Meropenem. Antimicrobial Agents and Chemotherapy, 45, 1343-1348. https://doi.org/10.1128/AAC.45.5.1343-1348.2001
|
[109]
|
Chu, Y.W., Afzal-Shah, M., Houang, E.T., Palepou, M.F., Lyon, D.J., Woodford, N. and Livermore, D.M. (2001) IMP-4, a Novel Metallo-β-Lactamase from Nosocomial Acinetobacter spp. Collected in Hong Kong between 1994 and 1998. Antimicrobial Agents and Chemotherapy, 45, 710-714. https://doi.org/10.1128/AAC.45.3.710-714.2001
|
[110]
|
Hawkey, P.M., Xiong, J., Ye, H., Li, H. and M’Zali, F.H. (2001) Occurrence of a New Metallo-β-Lactamase IMP-4 Carried on a Conjugative Plasmid in Citrobacter youngae from the People’s Republic of China. FEMS Microbiology Letters, 194, 53-57.
|
[111]
|
Da Silva, G.J., Correiam, M., Vital, C., Ribeiro, G., Sousa, J.C., Leitao, R., Peixe, L. and Duarte, A. (2002) Molecular Characterization of bla (IMP-5), a New Integron-Borne Metallo-β-Lactamase Gene from an Acinetobacter baumannii Nosocomial Isolate in Portugal. FEMS Microbiology Letters, 215, 33-39.
|
[112]
|
Gibb, A.P., Tribuddharat, C., Moore, R.A., Louie. T.J., Krulicki, W., Livermore, D. M., Palepou, M.F. and Woodford, N. (2002) Nosocomial Outbreak of Carbapenem-Resistant Pseudomonas aeruginosa with a New blaIMP Allele, blaIMP-7. Antimicrobial Agents and Chemotherapy, 46, 255-258. https://doi.org/10.1128/AAC.46.1.255-258.2002
|
[113]
|
Ho, S.E., Subramaniam, G., Palasubramaniam, S. and Navaratnam, P. (2002) Carbapenem-Resistant Pseudomonas aeruginosa in Malaysia Producing IMP-7 β-Lactamase. Antimicrobial Agents and Chemotherapy, 46, 3286-3287. https://doi.org/10.1128/AAC.46.10.3286-3287.2002
|
[114]
|
Bush, K. and Singer, S.B. (1989) Biochemical Characteristics of Extended Broad Spectrum β-Lactamases. Infection, 17, 429-433. https://doi.org/10.1007/BF01645566
|
[115]
|
Payne, D.J., Bateson, J.H., Gasson, B.C., Proctor, D., Khushi, T., Farmer, T.H, Tolson, D.A., Bell, D., Skett, P.W., Marshall, A.C., Reid, R., Ghosez, L., Combret, Y. and Marchand-Brynaert, J. (1997) Inhibition of Metallo-β-Lactamases by a Series of Mercaptoacetic Acid Thiol Ester Derivatives. Antimicrobial Agents and Chemotherapy, 41, 135-140. https://doi.org/10.1128/AAC.41.1.135
|
[116]
|
Gilpin, M.L., Fulston, M., Payne, D., Cramp, R. and Hood, I. (1995) Isolation and Structure Determination of Two Novel Phenazines from a Streptomyces with Inhibitory Activity against Metallo-Enzymes, Including Metallo-β-Lactamase. The Journal of Antibiotics, 48, 1081-1085. https://doi.org/10.7164/antibiotics.48.1081
|
[117]
|
Toney, J.H., Fitzgerald, P.M., Grover-Sharma, N., Olson, S.H., May, W.J., Sundelof, J.G., Vanderwall, D.E., Cleary, K.A., Grant, S.K., Wu, J.K., Kozarich, J.W., Pompliano, D.L. and Hammond, G.G. (1998) Antibiotic Sensitization Using Biphenyl Tetrazoles as Potent Inhibitors of Bacteroides Fragilis Metallo-β-Lactamase. Chemistry & Biology, 5, 185-196. https://doi.org/10.1016/S1074-5521(98)90632-9
|
[118]
|
Walter, M.W., Felici, A., Galleni, M., Soto, R.P., Adlington, R.M., Baldwin, J.E., Frere, J.M., Gololobov, M. and Schofield, C.J. (1996) Trifluoromethyl Alcohol and Ketone Inhibitors of Metallo-β-Lactamases. Bioorganic & Medicinal Chemistry Letters, 6, 2455-2458. https://doi.org/10.1016/0960-894X(96)00453-2
|
[119]
|
Bounaga, S., Laws, A.P., Galleni, M. and Page, M.I. (1998) The Mechanism of Catalysis and the Inhibition of the Bacillus cereus Zinc-Dependent β-Lactamase. Biochemical Journal, 331, 703-711. https://doi.org/10.1042/bj3310703
|
[120]
|
Mollard, C., Moali, C., Papamicael, C., Damblon, C., Vessilier, S., Amicosante, G., Schofield, C.J., Galleni, M., Frere, J.M. and Roberts. G. (2001) Theomandelic Acid, a Broad Spectrum Inhibitor of Zinc Beta-Lactamases. The Journal of Biological Chemistry, 276, 45015-45023. https://doi.org/10.1074/jbc.M107054200
|
[121]
|
Antony, J., Gresh, N., Olsen, L., Hemmingsen, L., Schofield, C.J. and Bauer, R. (2002) Binding of D- and L-Captopril Inhibitors to Metallo-Beta Lactamase Studied by Polarizable Molecular Mechanics and Quantum Mechanics. Journal of Computational Chemistry, 23, 1281-1296. https://doi.org/10.1002/jcc.10111
|
[122]
|
Buynak, J.D. (2004) The Discovery and Development of Modified Penicillin-and Cephalosporin-Derived β-Lactamase Inhibitors. Current Medicinal Chemistry, 11, 1951-1964. https://doi.org/10.2174/0929867043364847
|
[123]
|
Pagani, L., Colinon, C., Migliavacca, R., Labonia, M., Docquier, J.D., Nucleo, E., Spalla, M., Bergoli, M.L. and Rossolini, G.M. (2005) Nosocomial Outbreak Caused by Multidrug-Resistant Pseudomonas aeruginosa Producing IMP-13 Metallo-Beta-Lactamase. Journal of Clinical Microbiology, 43, 3824-3828. https://doi.org/10.1128/JCM.43.8.3824-3828.2005
|
[124]
|
Castanheira, M., Bell, J.M., Turnidge, J.D., Mathai, D. and Jones, R.N. (2009) Carbapenem Resistance among Pseudomonas aeruginosa Strains from India: Evidence for Nationwide Endemicity of Multiple Metallo-β-Lactamase Clones (VIM-2,-5,-6, and-11 and the Newly Characterized VIM-18). Antimicrobial Agents and Chemotherapy, 53, 1225-1227. https://doi.org/10.1128/AAC.01011-08
|
[125]
|
Peleg, A.Y., Franklin, C., Bell, J.M. and Spelman, D.W. (2005) Dissemination of the Metallo-Beta-Lactamase Gene blaIMP-4 among Gram-Negative Pathogens in a Clinical Setting in Australia. Clinical Infectious Diseases, 41, 1549-1556. https://doi.org/10.1086/497831
|
[126]
|
Walsh, T.R., Toleman, M.A., Poirel, L. and Nordmann, P. (2005) Metallo-β-Lactamases: The Quiet before the Storm? Clinical Microbiology Reviews, 18, 306-325. https://doi.org/10.1128/CMR.18.2.306-325.2005
|
[127]
|
Malkocoglu, G., Aktas, E., Bayraktar, B., Otlu, B. and Bulut, M.E. (2017) VIM-1, VIM-2, and GES-5 Carbapenemases among Pseudomonas aeruginosa Isolates at a Tertiary Hospital in Istanbul, Turkey. Microbial Drug Resistance, 23, 328-334. https://doi.org/10.1089/mdr.2016.0012
|
[128]
|
Jaurin, B. and Grundstrom, T. (1981) AmpC Cephalosporinase of Escherichia coli K-12 Has a Different Evolutionary Origin from That of Beta-Lactamases of the Penicillinase Type. Proceedings of the National Academy of Sciences of the United States of America, 78, 4897-4901. https://doi.org/10.1073/pnas.78.8.4897
|
[129]
|
Ouellette, M., Bissonnette, L. and Roy, P.H. (1987) Precise Insertion of Antibiotic Resistance Determinants into Tn21-Like Transposons: Nucleotide Sequence of the OXA-1 Beta-Lactamase Gene. Proceedings of the National Academy of Sciences of the United States of America, 84, 7378-7382. https://doi.org/10.1073/pnas.84.21.7378
|
[130]
|
Gherardini, P.F., Wass, M.N., Helmer-Citterich, M. and Sternberg, M.J.E. (2007) Convergent Evolution of Enzyme Active Sites Is Not a Rare Phenomenon. Journal of Molecular Biology, 372, 817-845. https://doi.org/10.1016/j.jmb.2007.06.017
|
[131]
|
Hall, B.G. and Barlow, M. (2005) Revised Ambler Classification of β-Lactamases. Journal of Antimicrobial Chemotherapy, 55, 1050-1051. https://doi.org/10.1093/jac/dki130
|
[132]
|
Frere, J.M., Galleni, M., Bush, K. and Dideberg, O. (2005) Is It Necessary to Change the Classification of β-Lactamases? Journal of Antimicrobial Chemotherapy, 55, 1051-1053. https://doi.org/10.1093/jac/dki155
|
[133]
|
Alderson, R.G., Barker, D. and Mitchell, J.B.O. (2014) One Origin for Metallo-β-Lactamase Activity, or Two? An Investigation Assessing a Diverse Set of Reconstructed Ancestral Sequences Based on a Sample of Phylogenetic Trees. Journal of Molecular Evolution, 79, 117-129. https://doi.org/10.1007/s00239-014-9639-7
|
[134]
|
Hall, B.G., Salipante, S.J. and Barlow, M. (2003) The Metallo-β-Lactamases Fall into Two Distinct Phylogenetic Groups. Journal of Molecular Evolution, 57, 249-254. https://doi.org/10.1007/s00239-003-2471-0
|
[135]
|
Brandt, C., Braun, S.D., Stein, C., Slickers, P., Ehricht, R., Pletz, M.W. and Makarewicz, O. (2017) In Silico Serine β-Lactamases Analysis Reveals a Huge Potential Resistome in Environmental and Pathogenic Species. Scientific Reports, 7, Article No. 43232. https://doi.org/10.1038/srep43232
|
[136]
|
Silveira, M.C., da Silva, R.A., da Mota, F.F., Catanho, M., Jardim, R., Guimaraes, A. C. and Miranda, A.B. (2018) Systematic Identification and Classification of β-Lactamases Based on Sequence Similarity Criteria: β-Lactamase Annotation. Evolutionary Bioinformatics, 14, 1-11. https://doi.org/10.1177/1176934318797351
|